Work

Combination of mitoxantrone hydrochloride liposome with tislelizumab in patients with relapsed or refractory NK/T cell lymphoma: A phase Ib/II study.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.7055

Authors: Qingqing Cai, Yi Xia, Liang Wang, Dongfeng Zeng, Hongyan Tong, Ying Zhao, Huiqiang Huang, Yuerong Shuang, Zhigang Peng, Xiaobo Wang, Xiuhua Sun, Yu Yang, Zhenya Hong, Runhui Zheng, Jinni Wang, Daoguang Chen, Jun Cai, Yan Gao, Yuchen Zhang, Xiaojie Fang

Institutions: Sun Yat-sen University Cancer Center, Beijing Tongren Hospital, Capital Medical University, Chinese People's Liberation Army, First Affiliated Hospital Zhejiang University, Zhejiang University, First People's Hospital of Foshan, Jiangxi Provincial Cancer Hospital, First Affiliated Hospital of GuangXi Medical University, Dalian Medical University, Second Affiliated Hospital of Dalian Medical University, Fujian Provincial Cancer Hospital, Tongji Hospital, Huazhong University of Science and Technology, Guangzhou Medical University

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410818119

Cites:

Cited by:

Related to: 10